Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Lewis

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
The Journal of Antimicrobial Chemotherapy|October 1, 2016
Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measuresPascale Trepanier, Kim Mallard, Danièle Meunier, et al.
Journal of Medicinal Chemistry|July 29, 2008
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug designPaul G Wyatt, Andrew J Woodhead, Valerio Berdini, et al.
Science (New York, N.Y.)|January 10, 2009
Unsung hero Robert C. GalloGiovanni Abbadessa, Roberto Accolla, Fernando Aiuti, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
The Journal of Antimicrobial Chemotherapy|October 1, 2016
Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measuresPascale Trepanier, Kim Mallard, Danièle Meunier, et al.
Journal of Medicinal Chemistry|July 29, 2008
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug designPaul G Wyatt, Andrew J Woodhead, Valerio Berdini, et al.
Science (New York, N.Y.)|January 10, 2009
Unsung hero Robert C. GalloGiovanni Abbadessa, Roberto Accolla, Fernando Aiuti, et al.
Pageof 9